- Home
- KYMR vs FFIN Comparison
KYMR vs FFIN Comparison
Compare KYMR & FFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KYMR | FFIN |
|---|---|---|
| Founded | 2015 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KYMR | FFIN |
|---|---|---|
| Price | $84.48 | $31.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 23 | 2 |
| Target Price | ★ $101.43 | $37.50 |
| AVG Volume (30 Days) | ★ 1.4M | 754.2K |
| Earning Date | 11-04-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | N/A | ★ 16.54 |
| EPS | N/A | ★ 1.69 |
| Revenue | $43,735,000.00 | ★ $581,881,000.00 |
| Revenue This Year | $20.81 | $21.45 |
| Revenue Next Year | N/A | $6.75 |
| P/E Ratio | ★ N/A | $18.70 |
| Revenue Growth | N/A | ★ 14.03 |
| 52 Week Low | $19.45 | $29.80 |
| 52 Week High | $103.00 | $41.47 |
Technical Indicators
Market Signals| Indicator | KYMR | FFIN |
|---|---|---|
| Relative Strength Index (RSI) | 63.93 | 51.26 |
| Support Level | $86.23 | $31.11 |
| Resistance Level | $93.82 | $32.10 |
| Average True Range (ATR) | 4.75 | 0.57 |
| MACD | 1.34 | 0.07 |
| Stochastic Oscillator | 52.51 | 49.79 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About FFIN First Financial Bankshares Inc.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto. It derives maximum revenue from Construction and Development Segment.